2-Fluoro-4-[7-[(Quinolin-6-Yl)Methyl]Imidazo[1,2-B][1,2,4]Triazin-2-Yl]Benzoic Acid

The primary applications of 2-Fluoro-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzoic acid lie in medicinal chemistry and cancer research. Its role as a c-Met inhibitor positions it as a candidate for therapeutic development against cancers characterized by aberrant c-Met signaling. Furthermore, its unique structure makes it a valuable tool for studying receptor-ligand interactions and signaling pathways in cellular biology.

This compound exhibits significant biological activity through its selective inhibition of the c-Met receptor tyrosine kinase, which is implicated in various cancer pathways. By binding to the c-Met receptor, including mutant variants associated with exon 14 skipping, it disrupts downstream signaling pathways such as STAT3, PI3K/AKT, and RAS/MAPK. This action results in the inhibition of cancer cell proliferation and survival in several tumor types. Studies indicate that it has a notable effect on cell viability and apoptosis in cancer models.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.